A bill to clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers; to the Committee on Finance.

S. 1423 — A bill to clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers; to the Committee on Finance.

By Mr. TOOMEY (for himself, Mr. Casey, and Mr. Wyden), S4960 [27JY]